Sulfonylureas and diabetes mellitus. I. Clinical evaluation
- PMID: 13365475
- DOI: 10.2337/diab.5.5.358
Sulfonylureas and diabetes mellitus. I. Clinical evaluation
Similar articles
-
Observations with sulfonylureas in diabetes.Metabolism. 1956 Nov;5(6 Part 2):864-7. Metabolism. 1956. PMID: 13378055 No abstract available.
-
Observations in diabetic subjects treated with sulfonylurea compounds.Diabetes. 1957 Jan-Feb;6(1):64-7; discussion, 85-90. doi: 10.2337/diab.6.1.64. Diabetes. 1957. PMID: 13397428 No abstract available.
-
[Experiences on 1,000 diabetics treated with sulfonylureas (BZ 55 and D 860)].Gaz Med Fr. 1957 Mar 25;64(6):519-24. Gaz Med Fr. 1957. PMID: 13427958 French. No abstract available.
-
Studies of the mechanism of action of sulfonylurea derivatives.Diabetes. 1957 Jan-Feb;6(1):53-4. doi: 10.2337/diab.6.1.53. Diabetes. 1957. PMID: 13397423 No abstract available.
-
The mechanism of action of the sulfonylureas in diabetes mellitus.Diabetes. 1957 May-Jun;6(3):263-9. doi: 10.2337/diab.6.3.263. Diabetes. 1957. PMID: 13427633 No abstract available.
Cited by
-
Patients With Type 2 Diabetes: Anesthetic Management in the Ambulatory Setting: Part 2: Pharmacology and Guidelines for Perioperative Management.Anesth Prog. 2017 Spring;64(1):39-44. doi: 10.2344/anpr-64-01-02. Anesth Prog. 2017. PMID: 28128657 Free PMC article. Review.
-
Synthetic protection short interfering RNA screen reveals glyburide as a novel radioprotector.Radiat Res. 2009 Oct;172(4):414-22. doi: 10.1667/RR1674.1. Radiat Res. 2009. PMID: 19772462 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources